Ranking of genome-wide association scan signals by different measures.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
MetadataShow full item record
AbstractBACKGROUND: The P-value approach has been employed to prioritizing genome-wide association (GWA) scan signals, with a genome-wide significance defined by a prior P-value threshold, although this is not ideal. A rationale put forward is that the association signals rather should be expected to give less support for single nucleotide polymorphisms (SNPs) that are rare (with associated low-power tests) than for common SNPs with equivalent P-values, unless investigators believe, a priori, that rare causative variants contribute to the disease and have more pronounced effects. METHODS: Using data from a GWA scan for type 2 diabetes (1924 cases, 2938 controls, 393 453 SNPs), we compared P-values with four alternative signal measures: likelihood ratio (LR), Bayes factor (BF; with a specified prior distribution for true effects), 'frequentist factor' (FF; reflecting the ratio between estimated--post-data-- 'power' and P-value) and probability of pronounced effect size (PrPES). RESULTS: The 19 common SNPs [minor allele frequency (MAF) among the controls >29%] yielding strong P-value signals (P < 5 x 10(-7)) were also top ranked by the other approaches. There was a strong similarity between the P-values, LR and BF signals, in terms of ranking SNPs. In contrast, FF and PrPES signals down-weighted rare SNPs (control MAF <10%) with low P-values. CONCLUSIONS: For prioritization of signals that do not achieve compelling levels of evidence for association, the main driving force behind observed differences between the various association signals appears to be SNP MAF. The statistical power afforded by follow-up samples for establishing replication should be taken into account when tailoring the signal selection strategy.
CitationInt. J. Epidemiol. 2009, 38 (5):1364-1373
SponsorsThis work was partly conducted within the EU Network of Excellence ECNIS (http://www.ecnis .org).
- Adiposity-related heterogeneity in patterns of type 2 diabetes susceptibility observed in genome-wide association data.
- Authors: Timpson NJ, Lindgren CM, Weedon MN, Randall J, Ouwehand WH, Strachan DP, Rayner NW, Walker M, Hitman GA, Doney AS, Palmer CN, Morris AD, Hattersley AT, Zeggini E, Frayling TM, McCarthy MI
- Issue date: 2009 Feb
- Replication of genome-wide association signals of type 2 diabetes in Han Chinese in a prospective cohort.
- Authors: Chang YC, Chiu YF, Liu PH, Shih KC, Lin MW, Sheu WH, Quertermous T, Curb JD, Hsiung CA, Lee WJ, Lee PC, Chen YT, Chuang LM
- Issue date: 2012 Mar
- A powerful hybrid approach to select top single-nucleotide polymorphisms for genome-wide association study.
- Authors: Wang J, Shete S
- Issue date: 2011 Jan 6
- Probability of detecting disease-associated single nucleotide polymorphisms in case-control genome-wide association studies.
- Authors: Gail MH, Pfeiffer RM, Wheeler W, Pee D
- Issue date: 2008 Apr
- Increasing power of genome-wide association studies by collecting additional single-nucleotide polymorphisms.
- Authors: Kostem E, Lozano JA, Eskin E
- Issue date: 2011 Jun